Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Unlocking a New Path to AML Treatment: Targeting the JMJD1C-RUNX1 Axis for Leukemia Progression Control

A new study has identified a critical mechanism that could lead to substantial advancements in the treatment of acute myeloid leukemia (AML). Researchers have discovered that the protein JMJD1C plays a pivotal role in leukemia cell survival. Specifically, JMJD1C is recruited by RUNX1 to genomic loci, where it forms liquid-like condensates.

March 3, 2025


March 13 2025

March 12 2025

March 11 2025

March 10 2025

March 9 2025

March 8 2025

March 7 2025

March 6 2025

March 5 2025

March 4 2025

March 3 2025

March 2 2025

February 28 2025